Loading...
Last update:  November 24, 2019
17:24 +1GMT

Allergenic Molecule  Bet v 2Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.9 - Pollen Allergy2014Czech RepublicIgE8269.40020140606, Panzner P
5.3.1 - Source Exposed (Symptoms, IgE)2014AustriaIgE21722.00020141002, Deifl S
1.11 - Esophagitis, Diagnosed2014SpainIgE677.40020140625, Armentia A
1.1 - Asymptomatic2014SpainIgE500.00020140625, Armentia A
1.9 - Pollen Allergy2014SpainIgE504.00020140625, Armentia A
1.12 - Oral Allergy Syndrome2014BelgiumIgE3818.42020140718, Faber MA
1.6 - Anaphylaxis, Diagnosed2014BelgiumIgE375.40020140718, Faber MA
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE3714.00020140127, Konradsen JR
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE287.00020140127, Konradsen JR
1.1 - Asymptomatic2014BelgiumIgE1526.67020140718, Faber MA
10.1 - Normal Control2014BelgiumIgE150.00020140718, Faber MA
1.5 - Atopic Dermatitis, Diagnosed2014BelgiumIgE140.00020140718, Faber MA
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1405.71020130111, Ott H
4.1.1 - Heterologous Source Sensitized (Symptoms)2013NetherlandsIgE8218.29020130415, Masthoff LJ
4.1.1 - Heterologous Source Sensitized (Symptoms)2013NetherlandsIgE7910.13020130415, Masthoff LJ
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE767.80020131020, van Rhijn BD
4.1.5 - Heterologous Source Sensitized (IgE)2013ChinaIgE4936.70020130624, Ma S
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2013ChinaIgE3834.20020130624, Ma S
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3537.14020130605, Simon D
4.1.5 - Heterologous Source Sensitized (IgE)2013ThailandIgE214.80020131011, Suratannon N
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2013ThailandIgE1915.80020131011, Suratannon N
5.3.1 - Source Exposed (Symptoms, IgE)2013ChinaIgE1631.25020130510, Ma S
6.2 - General Population (Adults)2012SwedenIgE3710.81020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9916.16020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE964.17020120528, Patelis A
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2012SpainIgE6819.10020120726, Pedrosa M
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE5514.50020120726, Pedrosa M
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012DenmarkIgE3010.00020120410, Ballmer-Weber BK
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012SwitzerlandIgE2129.00020120410, Ballmer-Weber BK
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012DenmarkIgE2015.00020120410, Ballmer-Weber BK
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012SpainIgE2015.00020120410, Ballmer-Weber BK
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012SwitzerlandIgE2035.00020120410, Ballmer-Weber BK
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012SpainIgE967.00020120410, Ballmer-Weber BK
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011ItalyIgE14838.51020110810, Pastorello EA
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011AustriaIgE14714.97020110121, Geroldinger-Simic M
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2011SwedenIgE7417.57020110701, Moverare R
4.1.5 - Heterologous Source Sensitized (IgE)2011ItalyIgE4397.67020110214, Villalta D
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164086.01020100301, Scala E
5.3.1 - Source Exposed (Symptoms, IgE)2010Czech RepublicIgE17821.30020101026, Sekerkova A
3.2.1 - Source Sensitized (IgE)2010SwedenIgE1007.00020100212, Asarnoj A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8616.27020101214, Gadisseur R
4.1.5 - Heterologous Source Sensitized (IgE)2010SwedenIgE500.00020100212, Asarnoj A
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2010ChinaIgE4413.63020101229, Han D
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2010ChinaIgE1723.53020101229, Han D
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2010ChinaIgE1330.77020101229, Han D
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009AustriaIgE5448.15020090416, Gaier S
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3716.21020090826, Ebo DG
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009SwitzerlandIgE2425.00020091005, Bauermeister K
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE224.55020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE210.00020090808, Krause S
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2075.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2010.00020091005, Ott H
5.3.1 - Source Exposed (Symptoms, IgE)2009SwitzerlandIgE2015.00020091005, Bauermeister K
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009SpainIgE1782.35020091215, Tordesillas L
4.1.5 - Heterologous Source Sensitized (IgE)2009ItalyIgE7100.00020091030, Quercia O
4.1.5 - Heterologous Source Sensitized (IgE)2008ItalyIgE24630.00020080613, Wopfner N
3.2.1 - Source Sensitized (IgE)2008JapanIgE5527.30020080319, Morita A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008GermanyIgE5014.00020081129, Treudler R
3.2.1 - Source Sensitized (IgE)2005FinlandIgE5513.00020041224, Moverare R
4.1.1 - Heterologous Source Sensitized (Symptoms)2005SwitzerlandIgE3933.30020050714, Ballmer-Weber BK
5.2.1 - Source Exposed (Symptoms, SPT)2005GermanyHRT3225.00020050218, Erdmann SM
5.2.1 - Source Exposed (Symptoms, SPT)2005GermanyIgE3215.60020050218, Erdmann SM
5.3.1 - Source Exposed (Symptoms, IgE)2005SwitzerlandIgE2133.30020050714, Ballmer-Weber BK
3.2.1 - Source Sensitized (IgE)2005Russian FederationIgE520.00020041224, Moverare R
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2004BelgiumIgE2420.80020040116, Ebo D
4.1.1 - Heterologous Source Sensitized (Symptoms)2004SwitzerlandIgE2222.70020040416, Westphal S
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2004Netherlands / SwitzerlandIgE2035.00020041204, Mittag D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004PolandIgE1421.00020050112, Cudowska B
4.1.5 - Heterologous Source Sensitized (IgE)2004Germany / SpainIgE (IB)11100.00020040416, Westphal S
5.3.1 - Source Exposed (Symptoms, IgE)2003ItalyIgE37244.60020030814, Rossi RE
3.1.1 - Source Sensitized (SPT)2003ItalyIgE37047.60020031005, Mari A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2003ItalyIgE8030.30020030816, Asero R
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2003SpainIgE7632.90020031017, Fernandez-Rivas M
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2003SwitzerlandIgE3426.50020030814, Tresch S
4.1.3 - Heterologous Source Sensitized (SPT)2003SpainIgE (IB)2951.70020030629, Rodriguez-Perez R
3.2.1 - Source Sensitized (IgE)2003AustriaIgE1010.0002003a, Westritschnig K
3.2.1 - Source Sensitized (IgE)2003ZimbabweIgE3100.0002003a, Westritschnig K
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002FranceIgE5120.0002002a, Moverare R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002AustriaIgE5030.0002002a, Moverare R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002SwedenIgE4212.0002002a, Moverare R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002FinlandIgE412.0002002a, Moverare R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002SwitzerlandIgE3743.0002002a, Moverare R
3.1.1 - Source Sensitized (SPT)2002FranceIgE3237.5002002a, Moverare R
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2002DenmarkIgE248.3002002, Luttkopf D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2002ItalyIgE2133.0002002a, Moverare R
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2002GermanyIgE (IB)1942.1002002, Reindl J
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2002SwitzerlandIgE1926.3002002, Luttkopf D
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2002GermanyIgE (IB)1643.7002002, Reindl J
4.1.3 - Heterologous Source Sensitized (SPT)2001ItalyIgE17755.0002001, Mari A
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2001ItalyIgE7733.800
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2001GermanyIgE3253.100
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2001SwitzerlandIgE2040.0002001, Ballmer-Weber BK
5.3.2 - Source Exposed (Symptoms, high IgE)2001GermanyIgE825.000
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2000GermanyIgE4216.700
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2000SwitzerlandIgE2227.300
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2000SwitzerlandIgE2227.300
3.2.1 - Source Sensitized (IgE)1999NetherlandsIgE22363.7001999, Van Ree R
4.1.5 - Heterologous Source Sensitized (IgE)1999GermanyIgE1573.300
5.2.1 - Source Exposed (Symptoms, SPT)1998AustriaIgE3818.400
5.2.1 - Source Exposed (Symptoms, SPT)1998AustriaSPT2035.000
5.2.1 - Source Exposed (Symptoms, SPT)1998SwitzerlandIgE185.500
5.4.1 - Source Exposed (Symptoms, SPT, IgE)1996ItalyIgE6556.9001996, Rossi RE
5.2.1 - Source Exposed (Symptoms, SPT)1996FranceIgE5119.6001996, Pauli G
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)1996SwitzerlandIgE (IB)5119.6001996, Menz G
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)1996FranceIgE388.000
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)1996SwedenIgE3511.000
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)1996AustriaIgE2914.000
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)1996DenmarkIgE2612.000
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)1996JapanIgE205.000
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)1996SwitzerlandIgE2015.000
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)1996CanadaIgE1513.000
Developed by
Panservice